$AYTU
Aytu Biopharma, Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Denver, CO
AYTU chart
What traders are saying about $AYTU
Latest postsAytu Biopharma, Inc news
- Aytu BioPharma to Report Fiscal 2027 First Quarter Operational and Financial Results on November 16, 2026
Yahoo Finance ·
- FDA Approval for ZOLPIMIST issued to AYTU
Quantisnow ·
- Aytu Biopharma Inc expected to post a loss of 26 cents a share - Earnings Preview
TradingView ·
- CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Aytu BioPharma, Inc. (AYTU) Seasonal returns chart
Yahoo Finance UK ·
- Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?
Yahoo Finance ·
- Aytu BioPharma, Inc. Q4 2026 Earnings Call Summary
app.moby.co ·
- Aytu BioPharma Inc (AYTU) (Q4 2026) Earnings Call Highlights: EXXUA Launch Accelerates as ...
Yahoo Finance ·
- Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
Yahoo Finance ·
- Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026
Yahoo Finance ·
- HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
Yahoo Finance ·
Aytu Biopharma, Inc key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $57.6M | $66.4M | $65.2M | $107.4M |
| Net income | -$14.3M | -$13.6M | -$15.8M | -$17.1M |
| Diluted EPS | – | – | – | $-5.11 |
| Total assets (year end) | – | $122.0M | $116.2M | $131.2M |
| Cash and equivalents (year end) | – | $30.0M | $20.4M | $19.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aytu Biopharma, Inc
- Ticker
- AYTU (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Denver, CO
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1385818
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
Frequently asked questions
What exchange is Aytu Biopharma, Inc listed on?
Aytu Biopharma, Inc trades on the Nasdaq under the ticker symbol AYTU.
What industry is Aytu Biopharma, Inc in?
Aytu Biopharma, Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aytu Biopharma, Inc headquartered?
Aytu Biopharma, Inc's business address on file with the SEC is in Denver, CO.
When does Aytu Biopharma, Inc's fiscal year end?
Aytu Biopharma, Inc's fiscal year ends on June 30.
How much revenue did Aytu Biopharma, Inc report?
Aytu Biopharma, Inc reported $57.6M in revenue for calendar year 2026, according to its SEC filings.